Blog - Research

Aeras invited Dr. Granger Sutton, Professor of Informatics and Prokaryotic Informatics Coordinator at the J. Craig Venter Institute (JCVI), to speak about sequencing Nontuberculous Mycobacteria (NTMs) and how a better understanding of NTM genomes can contribute to TB vaccine development.

On September 3, 2015, Aeras hosted the 2015 Fall meeting of the Biomarkers and Correlates Working Group (BCWG) in Rockville, Maryland. Tuberculosis (TB) experts from around the world attended to discuss and make recommendations for the TB vaccine community regarding studies needed to better define biomarkers or correlates for risk of TB infection or disease, protection induced by vaccination, and endpoints for clinical trials.

A recent media symposium in South Africa, organized by Aeras, IAVI, AVAC, HVTN and CAPRISA, provided training and cleared up misconceptions about clinical trials for local journalists.

Developing vaccines for tuberculosis represents a major global health priority and has been recognized as a critically important strategy to meet the World Health Organization’s ambitious goal of eliminating TB as a global health threat by 2035.

Professor Helen McShane is the lead author on a study funded in part by Aeras that was published in Lancet Respiratory Medicine in February. Dr. McShane sat down with Aeras to discuss how what was learned from this study and how it helps advance the field of TB vaccine research.